Evidence map›Paper›PMID 33879804›Full record

ArticleScientific reports2021

Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy).

Lorena Squillace, Lorenzo Pizzi, Flavia Rallo, Carmen Bazzani, Gianni Saguatti, Francesca Mezzetti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lorena SquillaceDepartment of Public Health, LHA Bologna, Via Boldrini, 12, 40121, Bologna, Italy. lorena.squillace@ausl.bologna.it.
Lorenzo PizziDepartment of Public Health, LHA Bologna, Via Boldrini, 12, 40121, Bologna, Italy.
Flavia RalloDepartment of Biomedical and Neuromotor Sciences, School of Hygiene and Preventive Medicine, University of Bologna, Bologna, Italy.
Carmen BazzaniDepartment of Public Health, LHA Bologna, Via Boldrini, 12, 40121, Bologna, Italy.
Gianni SaguattiDepartment of Oncology, LHA Bologna, Bologna, Italy.
Francesca MezzettiDepartment of Public Health, LHA Bologna, Via Boldrini, 12, 40121, Bologna, Italy.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a cross-sectional study to assess the likelihood of returning for routine breast cancer screening among women who have experienced a false-positive result (FPR) and to describe the possible individual and organizational factors that could influence subsequent attendance to the screening program. Several information were collected on demographic and clinical characteristics data. Electronic data from 2014 to 2016 related to breast screening program of the Local Health Authority (LHA) of Bologna (Italy) of women between 45 and 74 years old were reviewed. A total of 4847 women experienced an FPR during mammographic screening and were recalled to subsequent round; 80.2% adhered to the screening. Mean age was 54.2 ± 8.4 years old. Women resulted to be less likely to adhere to screening if they were not-Italian (p = 0.001), if they lived in the Bologna district (p < 0.001), if they had to wait more than 5 days from II level test to end of diagnostic procedures (p = 0.001), if the diagnostic tests were performed in a hospital with the less volume of activity and higher recall rate (RR) (p < 0.001) and if they had no previous participation to screening tests (p < 0.001). Our results are consistent with previous studies, and encourages the implementation and innovation of the organizational characteristics for breast cancer screening. The success of screening programs requires an efficient indicators monitoring strategy to develop and evaluate continuous improvement processes.

Indexed as

AgedBreast NeoplasmsCross-Sectional StudiesDiagnostic Screening ProgramsEarly Detection of CancerFalse Positive ReactionsFemaleHumansItalyMammographyMiddle AgedPatient ParticipationRetrospective StudiesTime Factors

Identifiers

PMID33879804
PMCPMC8058078
OpenAlexW3155180782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.